10 results
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... Treatment of Common ... Osteomyelitis - IDSA ... #pharmacology # ... idsa
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... #antimicrobials ... #pharmacology # ... dosing #idsa #drugs
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology ... #Management #CDiff
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
C.diff - Clostridioides ... non-toxigenic • Stool PCR ... Tx Management (IDSA ... /severe CDI IDSA ... ciab549 #CDI #Cdiff
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Illness: • Antimicrobial ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... drugs for use in a treatment ... #antimicrobials ... #pharmacology # ... ebm #idsa
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... #antimicrobials ... #regimens #pharmacology ... #dosing #idsa #
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... × 10 days #CDiff ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... recommended for KS treatment ... KaposiSarcoma #Castlemans #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... Pneumocystis #Pneumonia #IDSA ... #Prevention #Treatment ... HIVAIDS #management #pharmacology